Novo Nordisk (NVO): Overvalued Pharma That Should Be Rotated Here
Novo Nordisk is a popular holding due to its very liquid NYSE-listing NVO. Click here to know why I rate Novo Nordisk as a solid "HOLD" or rotation target here.
Source: seekingalpha.com